Our international team of research leaders combine both research expertise and publication know-how. Our team has a shared focus on innovative thinking, which is evident through our dedication to providing clients with the most cutting-edge solutions, services, and ideas available today. Contact us to talk about your research project or ideas.
PhD Molecular Neuroscience, University of Auckland
Dr McGowan was an Associate Editor of Nature Reviews Neuroscience, before joining Edanz in 2006. Prior to
working in the publishing industry, Dr McGowan was a Senior Scientist at the University of Cambridge, UK
and a Marie Curie Research Fellow at the Babraham Institute, also in Cambridge. He has more than ten years
of post-doctoral and post-graduate laboratory experience in the areas of neurodegenerative diseases,
molecular and cellular biology, protein biochemistry, proteomics and genomics. Daniel is a member of ISMPP
and is a Certified Medical Publications Professional.
PhD Biomedical Engineering, Tufts University
MD Medicine, Heidelberg University
Dr Atmanli is a biomedical engineer and physician-scientist with expertise in developmental biology,
tissue engineering, and human pluripotent stem cells. He obtained his PhD from Tufts University and has
since published work in journals including Cell Reports, Development, and Advanced Healthcare Materials.
MD MPH MS CPH PhD(c) Johns Hopkins Bloomberg School of Public Health
Dr. Popoola is a physician-epidemiologist with over 15 years of experience in clinical medicine,
epidemiological study design and implementation, outbreak investigation, and statistical analysis and
reporting using quantitative, qualitative, and mixed methodology. After several years of clinical medical
practice, Victor transitioned to public health.
PhD Biological Sciences, University of Warwick
James holds a PhD in Biochemistry and has a research background in prions and Parkinson's disease (The
Roslin Institute and DZNE Bonn). As Edanz' Science Director, he oversees our team to help researchers
develop innovative ideas and plan, design, run, and execute both clinical and non-clinical studies.
PhD Epidemiology, University at Albany, State University of New York
Dr Heavner has extensive research experience spending 5 years conducting HIV/AIDS research and program
evaluation at the AIDS Institute of the New York State Department of Health. She has conducted research on
epidemiology methods, environmental and occupational epidemiology, cancer epidemiology, autism spectrum
disease, HIV/AIDS, and viral hepatitis.
PhD Psychology, University of Auckland
Dr Iwabuchi has 15 years of research experience in the field of psychology, with specific expertise in
neuroimaging, psychiatry, mental health, and chronic pain. Most recently, she has been involved in a
clinical trial examining the efficacy of transcranial magnetic stimulation in the treatment of depression
using functional MRI, MR spectroscopy, and diffusion-weighted imaging.
PhD Cancer Biochemistry and Cell Biology, University of Cambridge
Dr March is a cancer biologist with special interests in cell signaling, intestinal oncology and cancer
stem cells. Dr March's has focused on the application of innovative models to identify and characterize
novel driver genes in colorectal cancer and is currently a Senior Bioscientist at the Paterson Institute
for Cancer Research in Manchester, UK, where she investigates novel oncology drug targets.
University of Melbourne
Our top biostatistician, Dr. Spelman, uses advanced methods to solve clinical epidemiology and health
research problems. He is especially creative, developing novel methods for analyzing time-to-event data
and assessing treatment effects.
PhD(c) Biomedicine and Health, University of Zagreb, School of Medicine
Dr Jelaković is currently a Gastroenterology and Hepatology resident at the University Hospital Center
Zagreb, Croatia, where he is training in cardiology, immunology, hematology, gastroenterology, and
hepatology. His areas of expertise also include biostatistics and epidemiology. He is currently working
toward his PhD in Biomedicine and Health, and his doctoral research is focused on carcinogenesis of
colorectal cancer in patients diagnosed with both primary sclerosing cholangitis and ulcerative colitis.
We attract the most creative and innovative experts in any given field and our expert team is limited to 300 members. Our rigorous hiring process means that even then, only 5% of applicants are accepted. This means that your project will receive personalized attention and solutions that are truly tailored to your needs.
Tom has a deep understanding of the needs of researchers and has spent over 15 years developing and marketing a variety of innovative products and services to support researchers. He is passionate about assisting researchers in effectively executing and communicating their work and reaching their full potential. Edanz has grown to become one of the world's most respected providers of research support and scientific communication services under his leadership.
Edanz Group's Chief Science Officer is Dr. Daniel McGowan. He has more than 20 years of experience in scientific research and publishing, including a senior research position at Cambridge University and a position as Associate Journal Editor for Nature Reviews Neuroscience. In his role at Edanz, Daniel is responsible for overseeing our entire solutions and services program. This includes working with our team of experts to develop creative and innovative solutions for our customers' needs. Daniel is also a member of our Executive Board, which establishes the strategic direction for the company, the core of which is to provide cutting-edge solutions for the challenges that modern researchers face.
We are a comprehensive research support service for the scientific community. This means we are committed to
providing innovative solutions to the challenges faced by the international research community, from
individual researchers and clinicians to large institutions. Edanz helps scientists reach their goals by
providing guidance and support at every stage of research planning, execution, writing, and publication
Edanz Pharma (evidence.edanz.com) supports Medical Affairs teams to plan and execute evidence generation strategies: gap and landscape analyses, publication planning, RWE studies including database and web surveys, meta analyses, manuscript development, and congress support.
Our teams include researchers, journal editors, peer reviewers, publication consultants, medical writers and medical communications specialists.
In 2019 we joined M3 Group (https://corporate.m3.com/); Tokyo Stock Exchange First Section (Securities code 2413).